HOME >> MEDICINE >> NEWS
Doctors at UVA health system search for new treatments for diabetic kidney disease

Kidney disease is a life-threatening complication of diabetes-- a disease marked by high levels of glucose in the blood because of defects in the way the body makes or uses insulin. For instance, in 2002, nearly 154,000 diabetic patients reached end-stage renal disease (ESRD) and were living on chronic dialysis or with a kidney transplant, according to the American Diabetes Association. That's more people than live in the entire city of Hampton, Va. Currently, the number of people in the United States with ESRD is about 300,000. That population is expected to double by 2010. The challenge for patients, their families, researchers, nurses and physicians is stopping the progression of kidney disease in its tracks in people with diabetes, potentially saving thousands of lives.

Research on one promising new treatment uses a growing body of evidence that inflammation may be a key cause of diabetic kidney disease.

Generally, inflammation is a nonspecific immune response to a type of bodily injury. Working with that idea, Dr. Mark Okusa, a nephrologist and professor of medicine at the University of Virginia Health System, has won two grants totaling $1.2 million over four years to test whether certain drugs can interrupt the inflammatory process that occurs in diabetic kidney disease. These drugs act on receptors for the compound adenosine. One drug, called ATL-146e, is licensed to the company Adenosine Therapeutics LLC of Charlottesville, Va. Preliminary results show that this drug prevents inflammation associated with acute kidney injury.

"We've been working with drugs affecting the adenosine system in acute kidney injury since the mid-1990's," Okusa said. "Why not take these concepts and apply them to treat chronic kidney disease?" Key members of the Okusa lab at UVa, including Dr. Alaa Awad and Mrs. Liping Huang, have found that adenosine drugs can prevent some of the most serious symptoms of diabetic kidney disease.

"In our laboratory
'"/>

Contact: Bob Beard
bobbeard@virginia.edu
434-982-4490
University of Virginia Health System
3-Jan-2006


Page: 1 2

Related medicine news :

1. Doctors have key role in preventing and detecting child neglect and abuse
2. Doctors conclude temsirolimus is effective new treatment for advanced renal cell carcinoma
3. Doctors, engineers develop new wireless system to detect esophageal reflux
4. Doctors ill equipped to confront parent smoking
5. Doctors test effort that helps people understand health risk information
6. Doctors neglect insomnia in older patients
7. Doctors extended duration work shifts are associated with medical errors and adverse events
8. Doctors working overseas face having licenses removed
9. Doctors must debate hospital closures
10. Doctors cut repeat LASIK visits dramatically
11. Doctors warn: Do not rely only on what young athletes say when managing concussions

Post Your Comments:
(Date:5/21/2013)... Five million Americans will buy a personal ... Liashek, owner of Studio South Fitness in ... at credentials and experience. The variation in education and ... trainer can pay $69.50 and get certified online in ... invest in themselves, A serious, professional trainer spends close ...
(Date:5/21/2013)... Third Generation Master Barber Greg Zorian is ... barbering DVDs. These DVDs include content from the HowToCutHair.tv ... cosmetology school or are current professionals, will no doubt ... teacher and mentor. , Today’s modern men’s hairstyles have ... 1960’s time period. In order to efficiently provide these ...
(Date:5/21/2013)... Tx. (PRWEB) May 21, 2013 Dallas-based ... peer- reviewed journal article testing the efficacy of their ... of eczema. The clinical study results appear in the ... , The article, “A Novel Sodium Hypochlorite Cleanser Shows ... Atopic Dermatitis,” reports impressive findings seen after consistent use ...
(Date:5/21/2013)... Everspark Interactive, one of the city's leading online ... the past year – and announced another milestone this ... efforts for Kids II, a designer of innovative baby ... local effort, specializing in search engine optimization (SEO) or ... website. The company now offers a host of boutique ...
(Date:5/21/2013)... Greenville, SC (PRWEB) May 21, 2013 ... be bringing the Philips Pocket Memo 8000, the newest ... around the country, providing a top-notch product for anyone ... recorder. The Pocket Memo 8000 is ... area few of the all-new digital voice recorder features ...
Breaking Medicine News(10 mins):Health News:Sarasota Fitness Tips: Choosing a Safe Trainer and Gym 2Health News:Sarasota Fitness Tips: Choosing a Safe Trainer and Gym 3Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 2Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 3Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 4Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 5Health News:First Series of Barbering DVDs Launched by Third Generation Master Barber Greg Zorian; DVDs Teach the Art of Men's Haircutting, Clipper Cutting, Fades and More 6Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 2Health News:Peer-Reviewed Article Shows CLn® BodyWash an Effective Solution for Children with Eczema 3Health News:Everspark Named Interactive Marketing Company for Kids II 2Health News:DTP Sales & Service Announces Upcoming Availability Of Philips Pocket Memo 8000 Series 2
(Date:5/21/2013)... 2013  Lehigh Valley Health Network has announced the ... adding to its existing arsenal of five 5-foot-5 germ-killing ... within the network, LVHN is now deploying the largest ... superbugs and provide the best possible patient care available. ... TRU-D – the signature product of Memphis ...
(Date:5/21/2013)...  Janssen R&D Ireland (Janssen) today announced primary ... 3 PROMISE study demonstrating that use of the ... virologic response 12 weeks after the end of ... 1 chronic hepatitis C adult patients with compensated ... when administered once daily with pegylated interferon and ...
(Date:5/21/2013)... , May 21, 2013  BioRestorative Therapies, Inc. ... sciences company focused on developing stem cell based therapies ... Weinreb , its President and CEO, will be ... The conference will be held on Thursday, May 30, ... E 42nd Street in New York City.  Mr. Weinreb,s ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
Cached News: